Glenmark Life Sciences share sale consists of a fresh issue of equities worth ₹1,060 crore and an offer for sale by promoter Glenmark Pharmaceuticals for ₹453 crore.
( read original story …)
The Taiwan NEWS
Glenmark Life Sciences share sale consists of a fresh issue of equities worth ₹1,060 crore and an offer for sale by promoter Glenmark Pharmaceuticals for ₹453 crore.
( read original story …)